ERBB2 and breast carcinoma: The aim of this study was to evaluate the expression of HER-2, estrogen (ER) and progesterone (PR) receptors in breast carcinoma and to compare it with other prognostic parameters such as histological type and grade, tumor size, patients' age, and lymph node metastases.